Sergine Brutus, PhD

Sergine Brutus Sweeney is a Venture Associate with Mass General Brigham Ventures focusing on new company creation. She is a translational scientist with a background in cell biology and biomarker development. Sergine previously led translational research programs at PathAI, where she oversaw AI-based histopathology biomarker development strategies for biopharma clients, with a focus on oncology. Sergine holds a BSc from Emory University and a PhD from Harvard University.